|Well, target (CD3xCD123) may be OK, but 4 days cont. infusion/3 days off dosing schedule....for how long.... 6, 9 or maybe 12 months...what about cumulative toxicity...somehow I see this as low priority.|
MGN0013, first let see single anti-PD-1 (MGA012), and if attractive profile (CELG paid a loot for it)...partner for single and bispecific may jump in and that is where payoff may come. Long term shot, so closely follow BMY on combination and others in play.
Hope, we will witness sun, one day with MGNX.
PS: From time to time, maybe there is not a bad idea to add few shares. It is not my prediction, but gut-feeling that will perform in time???!!!